News
Opinion: The law has to catch up on orphan-designated drugs with multiple uses
The law has to catch up on the 340B drug discount program, writes a pharmacist.
More in Health
- STAT+: NIH awarded all its grant funding, but delayed and opaque decisions stymied researchers STAT
- Royal College of Nursing cuts ties with Israeli drug company The Guardian — Society
- Coroner warns of risk of future deaths at mental health unit where patient was killed BBC News — Health
- Heat-related deaths in Phoenix rise, after two years of decline NPR — Health
- Medical Records Firm Uses AI Tool to Expose Flaws that Threaten Patient Privacy The New York Times — Health